Sel-Cap showed very high sensitivity (88%) for EGFR resistance mutation T790M in plasma samples, and among the 85 plasma samples tested, Sel-Cap identified 14 more T790M-positive samples which the PNAclamp tumor biopsy was unable to detect. The gene discussed is EGFR; the disease is neoplasm.